Potential Savings for Medicare Part D Enrollees Under Proposals to Add a Hard Cap on Out-of-Pocket Spending

Medicare Part D, the outpatient prescription drug benefit for Medicare beneficiaries, provides coverage above a catastrophic threshold for high out-of-pocket drug costs, but there is no cap on total out-of-pocket drug costs that beneficiaries pay each year. Recent legislative proposals would add a cap on out-of-pocket spending under Part D. This analysis focuses on the potential impact of different out-of-pocket spending caps in terms of how many beneficiaries would be affected and how much they could save.

Federal Register :: Medicare Program; Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public

Cost Caps and Coverage for All: How to Make Health Care Universally Affordable – Third Way

Medicare beneficiaries to receive Part D out-of-pocket cap

How Will the Prescription Drug Provisions in the Inflation Reduction Act Affect Medicare Beneficiaries?

Federal Register :: Medicare Program; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, Medicare Parts A, B, C, and

The Inflation Reduction Act Will Save Families Thousands of

Few Beneficiaries Know Part D Out-of-Pocket Cap Now in Effect - Medicare Rights Center

Seven ways to minimize your Medicare out-of-pocket costs

Tools to Reduce State Healthcare Costs

Federal Register :: Medicare Program; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, Medicare Parts A, B, C, and

Key Proposals to Strengthen the Affordable Care Act

Everything you need to know about Medicare reforms - PAN Foundation

Federal Register :: Medicare Program; Maximum Out-of-Pocket (MOOP) Limits and Service Category Cost Sharing Standards

What Are the Prescription Drug Provisions in the Inflation